These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 34315812)
1. Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking. Lucey M; Ashik T; Marzook A; Wang Y; Goulding J; Oishi A; Broichhagen J; Hodson DJ; Minnion J; Elani Y; Jockers R; Briddon SJ; Bloom SR; Tomas A; Jones B Mol Pharmacol; 2021 Oct; 100(4):319-334. PubMed ID: 34315812 [TBL] [Abstract][Full Text] [Related]
2. Disconnect between signalling potency and in vivo efficacy of pharmacokinetically optimised biased glucagon-like peptide-1 receptor agonists. Lucey M; Pickford P; Bitsi S; Minnion J; Ungewiss J; Schoeneberg K; Rutter GA; Bloom SR; Tomas A; Jones B Mol Metab; 2020 Jul; 37():100991. PubMed ID: 32278079 [TBL] [Abstract][Full Text] [Related]
3. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors. Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR J Biol Chem; 2021; 296():100133. PubMed ID: 33268378 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1. Marzook A; Chen S; Pickford P; Lucey M; Wang Y; Corrêa IR; Broichhagen J; Hodson DJ; Salem V; Rutter GA; Tan TM; Bloom SR; Tomas A; Jones B Biochem Pharmacol; 2021 Aug; 190():114656. PubMed ID: 34129856 [TBL] [Abstract][Full Text] [Related]
5. Reduced incretin receptor trafficking upon activation enhances glycemic control and reverses obesity in diet-induced obese mice. Bauri R; Bele S; Edelli J; Reddy NC; Kurukuti S; Devasia T; Ibrahim A; Rai V; Mitra P Am J Physiol Cell Physiol; 2024 Jul; 327(1):C74-C96. PubMed ID: 38738303 [TBL] [Abstract][Full Text] [Related]
6. Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells. Fang Z; Chen S; Manchanda Y; Bitsi S; Pickford P; David A; Shchepinova MM; Corrêa IR; Hodson DJ; Broichhagen J; Tate EW; Reimann F; Salem V; Rutter GA; Tan T; Bloom SR; Tomas A; Jones B Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182425 [TBL] [Abstract][Full Text] [Related]
13. Distinct roles of the extracellular surface residues of glucagon-like peptide-1 receptor in β-arrestin 1/2 signaling. Lei S; Meng Q; Liu Y; Liu Q; Dai A; Cai X; Wang MW; Zhou Q; Zhou H; Yang D Eur J Pharmacol; 2024 Apr; 968():176419. PubMed ID: 38360293 [TBL] [Abstract][Full Text] [Related]
14. Biased agonists with less glucagon-like peptide-1 receptor-mediated endocytosis prolong hypoglycaemic effects. Wu Q; Chen S; Zhu H; Xu N; Yang Q; Yao W; Gao X Eur J Pharmacol; 2021 Sep; 907():174203. PubMed ID: 34048741 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice. Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839 [TBL] [Abstract][Full Text] [Related]
16. Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1. Hager MV; Clydesdale L; Gellman SH; Sexton PM; Wootten D Biochem Pharmacol; 2017 Jul; 136():99-108. PubMed ID: 28363772 [TBL] [Abstract][Full Text] [Related]